GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Scienture Holdings SCNX · USD

Consumer Discretionary · US listing · 🇺🇸 United States

Compare

3.20

+2.24%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Scienture Holdings

From its filings with the US Securities and Exchange Commission

SEC filings

Scienture Holdings is based in Commack, New York and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker SCNX. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported revenue of $431,609 and a net loss of $41.5m. At that date it held total assets of $84.2m and shareholders' equity of $70.1m.

Read the filing on SEC.gov ↗

Company facts

Sector
Consumer Discretionary
Industry
Internet & Direct Marketing Retail
Listed since
26 Jan 2009
Employees
4
Head office
20 AUSTIN BLVD., COMMACK, NY, 11725
Incorporated in
DE
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Dr. Shankar HariharanExecutive Chairman of the Board, Co-Chief Executive Officer, since 2024
  • Dr. Narasimhan ManiPresident, Co-Chief Executive Officer, Director, since 2024
  • Mr. Eric SherbChief Financial Officer
  • Mr. Mayur DoshiIndependent Director
  • Mr. Donald FellIndependent Director$190,693
  • Mr. Subbarao JayanthiIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Trxade Group's e-commerce platform offers buyer/seller pricing algorithms for pharmaceuticals.
  • Delivmeds mobile app enables home delivery of medications across the US.
  • BonumHealth telemedicine portal supports virtual healthcare consultations nationwide.

Weaknesses

  • Only 4 employees at Scienture Holdings Inc. compared to Trxade Group's 29 staff.
  • Land O' Lakes, Florida headquarters lacks major pharmaceutical industry presence.
  • Limited to US operations without international expansion plans mentioned.

Opportunities

  • Growing demand for telemedicine services like BonumHealth in the US market.
  • Expansion of specialty pharmacy services to new US regions with Delivmeds.
  • Increasing adoption of e-commerce platforms in the pharmaceutical retail sector.

Threats

  • Competition from established pharmaceutical retailers in the US market.
  • Regulatory changes affecting telemedicine and online pharmacy services.
  • Economic downturns reducing consumer spending on non-essential medications.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.